The Scientist - Home

If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.

We mourned the closing of our lab. But then we got back to work—finding the balance between scholarly relevance and adapting to life in a world of new social norms.

President Donald Trump claims the World Health Organization failed to investigate early reports of the coronavirus, while public health experts argue that stripping the agency of its funding endangers us all.

Studies from serum samples could transform our understanding of the spread of COVID-19, but what antibodies alone say about immunity is not yet clear.

Folding@Home, currently focused on deciphering the workings of SARS-CoV-2, is the first project to have exascale-level computational muscle.

By studying influenza in mice and cells, researchers identify a glucose metabolism pathway critical to the dysregulated immune response that kills many infectious disease patients, including those with COVID-19.

The search for SARS-CoV-2 RNA in 60 saliva samples yielded the same results as conventional nasal swab tests taken from the same patients.

The recent cases come just as Democratic Republic of Congo was set to declare the outbreak’s end.

Researchers are offering tools, equipment, time, and expertise to help alleviate COVID-19 suffering. Here’s how you can chip in.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

Scientists at academic labs equipped to test for SARS-CoV-2 report that multiple barriers are preventing from them from operating at full capacity.

Researchers slowed disease progression in the mice by injecting two different viral vectors, each containing one part of the DNA encoding the Cas9 protein, to edit the causative gene.